BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38532715)

  • 21. Evidence of kinetic control of ligand binding and staged product release in MurA (enolpyruvyl UDP-GlcNAc synthase)-catalyzed reactions .
    Jackson SG; Zhang F; Chindemi P; Junop MS; Berti PJ
    Biochemistry; 2009 Dec; 48(49):11715-23. PubMed ID: 19899805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysine 22 in UDP-N-acetylglucosamine enolpyruvyl transferase from Enterobacter cloacae is crucial for enzymatic activity and the formation of covalent adducts with the substrate phosphoenolpyruvate and the antibiotic fosfomycin.
    Samland AK; Amrhein N; Macheroux P
    Biochemistry; 1999 Oct; 38(40):13162-9. PubMed ID: 10529188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning, expression and characterization of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Wolbachia endosymbiont of human lymphatic filarial parasite Brugia malayi.
    Shahab M; Verma M; Pathak M; Mitra K; Misra-Bhattacharya S
    PLoS One; 2014; 9(6):e99884. PubMed ID: 24941309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance.
    McCoy AJ; Sandlin RC; Maurelli AT
    J Bacteriol; 2003 Feb; 185(4):1218-28. PubMed ID: 12562791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the MurA enzyme in Fusobacterium nucleatum by potential inhibitors identified through computational and in vitro approaches.
    Kumar A; Saranathan R; Prashanth K; Tiwary BK; Krishna R
    Mol Biosyst; 2017 May; 13(5):939-954. PubMed ID: 28358152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the loop containing residue 115 in the induced-fit mechanism of the bacterial cell wall biosynthetic enzyme MurA.
    Schönbrunn E; Eschenburg S; Krekel F; Luger K; Amrhein N
    Biochemistry; 2000 Mar; 39(9):2164-73. PubMed ID: 10694381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead.
    Grabrijan K; Hrast M; Proj M; Dolšak A; Zdovc I; Imre T; Petri L; Ábrányi-Balogh P; Keserű GM; Gobec S
    Eur J Med Chem; 2022 Dec; 243():114752. PubMed ID: 36126388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli.
    Kumar S; Parvathi A; Hernandez RL; Cadle KM; Varela MF
    Arch Microbiol; 2009 May; 191(5):425-9. PubMed ID: 19277606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory mechanism of novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferase from Haemophilus influenzae.
    Jin BS; Han SG; Lee WK; Ryoo SW; Lee SJ; Suh SW; Yu YG
    J Microbiol Biotechnol; 2009 Dec; 19(12):1582-9. PubMed ID: 20075623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate and inhibitor-induced conformational changes in the structurally related enzymes UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate 3-phosphate synthase (EPSPS).
    Krekel F; Oecking C; Amrhein N; Macheroux P
    Biochemistry; 1999 Jul; 38(28):8864-78. PubMed ID: 10413459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modeling and bioinformatical analysis of the antibacterial target enzyme MurA from a drug design perspective.
    Klein CD; Bachelier A
    J Comput Aided Mol Des; 2006; 20(10-11):621-8. PubMed ID: 17124631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nature of Staphylococcus aureus MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors.
    Blake KL; O'Neill AJ; Mengin-Lecreulx D; Henderson PJ; Bostock JM; Dunsmore CJ; Simmons KJ; Fishwick CW; Leeds JA; Chopra I
    Mol Microbiol; 2009 Apr; 72(2):335-43. PubMed ID: 19298367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments.
    Gautam A; Rishi P; Tewari R
    Appl Microbiol Biotechnol; 2011 Oct; 92(2):211-25. PubMed ID: 21822642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new view of the mechanisms of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) and 5-enolpyruvylshikimate-3-phosphate synthase (AroA) derived from X-ray structures of their tetrahedral reaction intermediate states.
    Eschenburg S; Kabsch W; Healy ML; Schonbrunn E
    J Biol Chem; 2003 Dec; 278(49):49215-22. PubMed ID: 13129913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidating the inhibition of peptidoglycan biosynthesis in Staphylococcus aureus by albocycline, a macrolactone isolated from Streptomyces maizeus.
    Liang H; Zhou G; Ge Y; D'Ambrosio EA; Eidem TM; Blanchard C; Shehatou C; Chatare VK; Dunman PM; Valentine AM; Voelz VA; Grimes CL; Andrade RB
    Bioorg Med Chem; 2018 Jul; 26(12):3453-3460. PubMed ID: 29805074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of compound library identifies novel inhibitors against the MurA enzyme of Escherichia coli.
    Raina D; Tiwari H; Sharma S; Deepika ; Chinthakindi PK; Nargotra A; Sangwan PL; Eniyan K; Bajpai U; Vishwakarma RA; Khan FG; Saran S; Khan IA
    Appl Microbiol Biotechnol; 2021 May; 105(9):3611-3623. PubMed ID: 33860835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two active forms of UDP-N-acetylglucosamine enolpyruvyl transferase in gram-positive bacteria.
    Du W; Brown JR; Sylvester DR; Huang J; Chalker AF; So CY; Holmes DJ; Payne DJ; Wallis NG
    J Bacteriol; 2000 Aug; 182(15):4146-52. PubMed ID: 10894720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA.
    Mendgen T; Scholz T; Klein CD
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5757-62. PubMed ID: 20729083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structures of active fully assembled substrate- and product-bound complexes of UDP-N-acetylmuramic acid:L-alanine ligase (MurC) from Haemophilus influenzae.
    Mol CD; Brooun A; Dougan DR; Hilgers MT; Tari LW; Wijnands RA; Knuth MW; McRee DE; Swanson RV
    J Bacteriol; 2003 Jul; 185(14):4152-62. PubMed ID: 12837790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of New Inhibitors of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) by Virtual Screening with Antibacterial Assessment.
    Boulhissa I; Chikhi A; Bensegueni A; Ghattas MA; Mokrani EH; Alrawashdeh S; Obaid DEE
    Curr Comput Aided Drug Des; 2021; 17(2):214-224. PubMed ID: 32053077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.